Keywords: Teva Pharma Industries, Cephalon, First-quarter 2012 financial results

Israel'sTeva beats expectations with 40% leap in profit

Article | 09 May 2012

Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) has reported a robust set of first-quarter 2012 financial results, with net revenues rising 25% to $5.1 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Cephalon

Teva Pharmaceutical Industries

Go to company listing